PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
10-Mar-2026 RGNX's Inadequate Risk Disclosures Allegedly Cost Investors $2.40/Share: Levi & Korsinsky, LLP Businesswire
10-Mar-2026 TIXiMED Announces Promising Preclinical Data: Oral TIX100 Prevents Weight Regain After GLP-1 Cessation in Obesity Model Businesswire
10-Mar-2026 Unreasonable Labs Raises $13.5M Funding Round to Scale Superintelligence for Knowledge Discovery Businesswire
10-Mar-2026 TerSera Therapeutics Announces Closing of Divestiture of Infusion Specialty Therapies Business Unit to ESTEVE Businesswire
10-Mar-2026 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
10-Mar-2026 CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth ACCESS Newswire
10-Mar-2026 ConnectiveRx Advances Clinically Integrated Provider Engagement Network Businesswire
10-Mar-2026 kyron.bio Announces Strategic Partnership with Servier to Advance Precision Glycosylation in Antibody Therapeutics kyron.bio
10-Mar-2026 BIOCAPTIVA secures £1.58M to transform how blood samples are prepared for liquid biopsy BIOCAPTIVA
10-Mar-2026 The $30 Billion CBD Question: Should Medicare Reimburse Cannabis Products Without FDA Approval? ACCESS Newswire
10-Mar-2026 CueZen AI Demonstrates Nation-Scale Health Impact in Singapore Businesswire
10-Mar-2026 Odyssey Therapeutics Appoints H. Martin Seidel, Ph.D., to Scientific Advisory Board Businesswire
10-Mar-2026 DTG Appoints Philip Sullivan Executive Vice President Businesswire
10-Mar-2026 Trialbee Appoints Accomplished Life Sciences Executive Rick Riegel to Board of Directors to Accelerate Global Patient Recruitment for Clinical Trials Businesswire
10-Mar-2026 Niagen Bioscience Launches Niagen® Skincare Innovation Lab and Debuts Dermatologist-Tested Niagen NanoCloud™, From Tru Niagen Powered by Patented Niagen® Businesswire
10-Mar-2026 MindImmune Secures $5 Million Strategic Investment from the Alzheimer’s Drug Discovery Foundation to Pioneer Immune-Driven Therapies for Alzheimer’s Disease Businesswire
10-Mar-2026 Casma Therapeutics Receives MJFF Support to Advance Research on TRPML1 in Parkinson’s Disease Businesswire
10-Mar-2026 bioAffinity Technologies Announces Initiation of Large-Scale Longitudinal Clinical Study for Its Noninvasive CyPath® Lung Cancer Diagnostic Businesswire
10-Mar-2026  Qlaris Bio Appoints Fred Guerard, Pharm.D., as President and Chief Executive Officer Businesswire
10-Mar-2026 BeOne’s Tislelizumab Now Available in Ireland, Offering a New First Line Immunotherapy Option for Advanced Oesophageal Cancer BeOne